SCHEMBL21701152

SCHEMBL21701152

COc1ccc(C(/C=C/c2c(C)cc(C)cc2C)OC(C)=O)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 1/20 0.40
RAPGEF4 Q8WZA2 1/20 0.40
GABRG2 P18507 1/20 0.38
GABRB3 P28472 1/20 0.38
GABRA3 P34903 1/20 0.38
FFAR4 Q5NUL3 1/20 0.38
ALDH1A1 P00352 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
TDP1 Q9NUW8 1/20 0.36
PTGS2 P35354 4/20 0.36
AKR1C3 P42330 3/20 0.36
AKR1C2 P52895 3/20 0.36
PTGS1 P23219 3/20 0.36
TSHR P16473 2/20 0.36
CDC42 P60953 1/20 0.36
RAC1 P63000 1/20 0.36
CYP1A2 P05177 1/20 0.36
SLC22A6 Q4U2R8 1/20 0.36
TUBB4A P04350 1/20 0.36
TUBB P07437 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21701145 0.81 CYP3A4 (0.51) ALDH1A1TSHRTUBB4ATUBBTUBA3C
SCHEMBL23873713 0.81 MAOB (0.38) FFAR4ALDH1A1L3MBTL1TDP1PTGS2
SCHEMBL21701156 0.80 MAOB (0.41) ALDH1A1L3MBTL1TDP1TSHRMAPT
SCHEMBL21701167 0.78 TUBB4A (0.37) ALDH1A1L3MBTL1TUBB4ATUBBTUBA3C
SCHEMBL3233663 0.76 RAPGEF4 (0.47) ABCB1RAPGEF4GABRG2GABRB3GABRA3
SCHEMBL1194620 0.76 RAPGEF4 (0.47) ABCB1RAPGEF4GABRG2GABRB3GABRA3
SCHEMBL29034768 0.73 MAPT (0.44) ALDH1A1TDP1LMNAMAPT
SCHEMBL27100252 0.72 CYP3A4 (0.46) ALDH1A1LMNAMAPTCYP2C9
SCHEMBL23873780 0.72 MAOB (0.56) TDP1PTGS2PTGS1CYP1A2MAPT
SCHEMBL5498232 0.68 RELA (0.66) ABCB1ALDH1A1PTGS2PTGS1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11912704-B2 Methods and compositions for substituted arylcycloheptane analogs UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2024-02-27 US disclosed
US-20210300928-A1 METHODS AND COMPOSITIONS FOR SUBSTITUTED ARYLCYCLOHEPTANE ANALOGS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. 2021-09-30 US disclosed
WO-2020033567-A1 METHODS AND COMPOSITIONS FOR SUBSTITUTED ARYLCYCLOHEPTANE ANALOGS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION (US) 2020-02-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210300928-A1 METHODS AND COMPOSITIONS FOR SUBSTITUTED ARYLCYCLOHEPTANE ANALOGS AHR, HCCS, HMBS ABCB1 195/4885RAPGEF4 3116/4885GABRG2 3629/4885
US-11912704-B2 Methods and compositions for substituted arylcycloheptane analogs AHR, HCCS, HMBS ABCB1 195/4885RAPGEF4 3116/4885GABRG2 3629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.